openPR Logo
Press release

Indian IBD Therapeutics Market Growth, Opportunity, Size, Share and Forecast 2019-2025

03-13-2020 11:07 AM CET | Health & Medicine

Press release from: Orion Market Research

Indian IBD therapeutics market is estimated to grow significantly at a CAGR of around 6.2% during the forecast period. The Indian pharmaceutical industry has been consistently growing with the public and private investments, making India as a potential market for the treatment of prevailing diseases such as IBD. Additionally, healthcare expenditure is playing a critical role in fueling the IBD therapeutics market in India.

Request a Free Sample of our Report on Indian IBD Therapeutics Market: https://www.omrglobal.com/request-sample/indian-ibd-inflammatory-bowel-disease-therapeutics-market

With the substantial healthcare expenditure and various insurance schemes including PMJAY and Ayushman Bharat-National Health Protection Mission, the healthcare sector is improving on various fronts in India. Various aspects in which the Indian healthcare sector is improving upon includes a number of healthcare services, advanced diagnostic centers, induction of advanced treatment process, international collaborations, and developing infrastructure for healthcare services that further provide a significant opportunity to the market growth.

Indian IBD therapeutics market is segmented on the basis of disease type and treatment type. The disease type segment includes ulcerative colitis and Crohn's disease. Crohn's disease segment is estimated to dominate the market. The growth of the segment is attributed to the comparatively higher incidence of Crohn's disease than ulcerative colitis. For Crohn's and ulcerative colitis, the development of minimally invasive methods has been evolved with more caution as compared to other colorectal diseases.

This is primarily due to disease-related characteristics that are concerned with IBD. The treatment type segment is further segmented into anti-inflammatory drugs and surgery. There is a range of anti-inflammatory drugs used for the treatment of IBD, such as immunosuppressants (methotrexate, ciclosporin, and azathioprine), steroids and biological drugs. Steroids are commonly referred to as Corticosteroids. This enables to reduce inflammation in the digestive tract and provides relief from symptoms of IBD condition. For several people, corticosteroids have a potential anti-inflammatory effect that starts working very rapidly.

A Full Report of Indian IBD Therapeutics Market is Available at https://www.omrglobal.com/industry-reports/indian-ibd-inflammatory-bowel-disease-therapeutics-market

Indian IBD Therapeutics Market

By Disease Type
o Ulcerative Colitis
o Crohn's Disease

By Treatment Type
o Surgery
o Anti- Inflammatory Drug Administration
o Steroids
o Immunosuppressant
o Biological Drugs
o Amino salicylates
o Others

Company Profiles
o AbbVie Inc.
o Allergan, PLC
o Boehringer Ingelheim International GmbH
o Daiichi Sankyo Co. Ltd.
o Eli Lilly and Co.
o Johnson & Johnson Services Inc.
o Mercator Pharmaceutical Solutions
o Pfizer Inc.
o RPG Life Sciences Ltd.
o Sanofi S.A.
o Takeda Pharmaceutical Co., Ltd.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/indian-ibd-inflammatory-bowel-disease-therapeutics-market

For More Information, Visit https://www.omrglobal.com/

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 780-304-0404

About us:

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Indian IBD Therapeutics Market Growth, Opportunity, Size, Share and Forecast 2019-2025 here

News-ID: 1966228 • Views:

More Releases from Orion Market Research

Winter Wear Market Update Report 2024 | Industry Trends, Demand, Leading Companies and Segmentation till 2031/ Amer Sports,Benetton Group ,Chogori India Retail Ltd.
Winter Wear Market Update Report 2024 | Industry Trends, Demand, Leading Compani …
The global Winter Wear market is anticipated to grow at a considerable CAGR of 4.9% during the forecast period (2024-2031). The winter wear market is focusing on technologies to improve the quality of their product. The companies are now focused towards launching the winter wear equipped with the smart technology. For instance, In February 2018, the Ministry of Supply- the Boston Company has introduced a self-heating smart jacket. The heated
Tube Packaging Market Size, Share, Trends, Demand, Segments, Leading Companies and Forecast till 2031 / Albéa Services S.A.S., ALLTUB SAS, Amcor PLC
Tube Packaging Market Size, Share, Trends, Demand, Segments, Leading Companies a …
The most successful brands rely on data to inform, and gauge their strategy and decision making, from their marketing segmentation to the product features they develop. This Tube Packaging Market study report also aims at providing important market growth updates to enable business owners devise crucial marketing strategies. Business related decision making completely relies on market data and here comes the role of Tube Packaging Market research report. Making insight-driven
Self-Tanning Products Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031/ The Lip Lab Avalon, L'Oréal USA, PZ Cussons (UK) LTD.
Self-Tanning Products Market Size, Trends, Latest Insights, Analysis and Forecas …
The global self-tanning product market is anticipated to grow at a considerable CAGR of 6.2% during the forecast period. The increasing demand for non-toxic and organic self-tanning products is driving the growth of the global self-tanning products market. The growing concern among people about skin diseases and allergies made people use vegan and organic beauty products which motivating beauty industry to adopt organic product or products with minimum chemical content
Sachet Packaging Market Outlook 2024-2031: Trends and Opportunities/ AE Adams (Henfield), Ltd., Amcor, Ltd., Bemis Co., Inc.
Sachet Packaging Market Outlook 2024-2031: Trends and Opportunities/ AE Adams (H …
Sachet are the small sealed bags which are used to store powder or liquid product such as coffee, sauces, shampoo, oil, sugar, tea and lubricant among others. The primary purpose of manufacturing sachet packaging solutions was to target low-income group people and focusing on the largest mass market. Moreover, sachet packaging is cost-effective in both distribution and packaging as it minimizes the waste of the raw material due to which

All 5 Releases


More Releases for IBD

Canada Inflammatory Bowel Disease (IBD) Market Size & Growth Analysis Report, 20 …
The Canada IBD market is estimated to grow significantly at a CAGR of around 5.2% during the forecast period. Rising prevalence and incidence of IBD across the country is the major driving factor for the market. Canada has among the highest reported prevalence and incidence rates of IBD across the globe. As per CCC, in 2018, nearly 270,000 Canadians were living with IBD, of which 135,000 individuals with Crohn’s disease,
Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031
Visiongain has published a new report on Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031: Forecasts by Drug Class (Biologics, Aminosalicylates, Corticosteroids, Antibiotics, Immunomodulators, Others), by Indication (Crohn’s Disease, Ulcerative Colitis), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) AND Regional and Leading National Market Analysis PLUS Analysis of Leading IBD Drug Companies AND COVID-19 Recovery Scenarios. Global Inflammatory Bowel Disease (IBD) drugs market was valued at US$ US$xx
US Inflammatory Bowel Disease (IBD) Therapeutics Market Research and Forecast 20 …
The US IBD therapeutics market is estimated to grow significantly at a CAGR of around 4.7% during the forecast period. The factors such as the significant prevalence of IBD such as Crohn’s disease and ulcerative colitis across the country contributing to the market growth. As per the Centers for Disease Control and Prevention (CDC), the prevalence of Crohn’s disease and ulcerative colitis in the US was 201 and 238 per
France Inflammatory Bowel Disease (IBD) Therapeutics Market Size, Growth and For …
France IBD therapeutics market is estimated to grow significantly at a CAGR of around 4.6% during the forecast period. The growing IBD patient population is one of the major driving forces for the growth of the market in the country. According to the National Institutes of, Health, the total number of cases associated with Crohn's disease in France were registered to be around 72,522 in 2017. This signifies the opportunity
Global Inflammatory Bowel Disease (IBD) Therapeutics Market, Share, Trends & For …
The global IBD therapeutics market is estimated to grow significantly at a CAGR of around 5.0% during the forecast period. The rise in the number of IBD such as Crohn's disease and ulcerative colitis is augmenting the growth of the global IBD therapeutics market. The increasing prevalence of IBD results in the need for research for the treatment of IBD and innovations in healthcare systems to manage this complex and
Canada Inflammatory Bowel Disease (IBD) Market Share, Size & Forecast to 2025
The Canada IBD market is estimated to grow significantly at a CAGR of around 5.2% during the forecast period. Rising prevalence and incidence of IBD across the country is the major driving factor for the market. Canada has among the highest reported prevalence and incidence rates of IBD across the globe. As per CCC, in 2018, nearly 270,000 Canadians were living with IBD, of which 135,000 individuals with Crohn's disease,